학술논문

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Source
In The Lancet 23-29 September 2017 390(10101):1489-1498
Subject
Primary Research
Articles
Language
ISSN
0140-6736